\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes EICThe European Innovation Council and SMEs Executive Agency (EISMEA) is launching a Call for Expression of Interest for the recruitment of three candidates for the position of European Innovation Council (EIC) Programme Manager (PM) and the establishment of a reserve list. This call is aimed at candidates with expertise in the following three thematic areas:
EIC PMs are high-level experts in specific fields of technology, business and innovation and who manage one or more EIC Portfolios. They are appointed to work in the Agency for a limited duration, in order to develop visions for breakthrough technologies and innovations, and to proactively manage portfolios of projects to achieve these breakthroughs. They are supported by EIC Project Officers as well as by EIC Tech to Market advisers. The EIC PMs are subject to strict rules concerning conflicts of interest and confidentiality.
The deadline for applications is 26 January 2024 12:00 Brussels time.
All information on the Call for EoI including on the EIC, job description, professional qualifications & other requirements and the selection & application procedure can be found in this announcement.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
